Ayala Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ayala Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 11.9M shares, a 349% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 11.9M +9.22M +349% Dec 31, 2023 10-K 2024-04-16
Q3 2023 4.79M +2.97M +164% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 4.78M +2.96M +163% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 4.77M +2.95M +162% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 2.64M -143M -98.2% Dec 31, 2022 10-K 2024-04-16
Q3 2022 1.82M -4.5K -0.25% Oct 31, 2022 10-K 2023-02-10
Q2 2022 1.82M -144M -98.8% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 1.82M -144M -98.8% Apr 30, 2022 10-Q 2022-06-08
Q4 2021 146M +29.5M +25.4% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 1.82M -76.3M -97.7% Oct 31, 2021 10-K 2023-02-10
Q2 2021 146M +82.9M +132% Jul 31, 2021 10-Q 2021-09-10
Q1 2021 146M +85.4M +142% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 116M +55.9M +92.8% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 78.1M +27.9M +55.5% Oct 31, 2020 10-K 2022-02-14
Q2 2020 62.7M +43.5M +226% Jul 31, 2020 10-Q 2020-09-10
Q1 2020 60.3M +52.2M +651% Apr 30, 2020 10-Q 2020-06-11
Q4 2019 60.2M -9.5M -13.6% Jan 31, 2020 10-Q 2020-03-13
Q3 2019 50.2M +45.6M +983% Oct 31, 2019 10-K 2021-01-22
Q2 2019 19.2M -33.6M -63.5% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 8.02M -44.5M -84.7% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 69.7M +27.5M +64.9% Jan 31, 2019 10-Q 2019-03-12
Q3 2018 4.63M -36.6M -88.8% Oct 31, 2018 10-K 2019-12-20
Q2 2018 52.8M +11.8M +28.8% Jul 31, 2018 10-Q 2018-09-10
Q1 2018 52.6M +12.2M +30.1% Apr 30, 2018 10-Q 2018-06-07
Q4 2017 42.3M +2.1M +5.22% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 41.2M +1.17M +2.91% Oct 31, 2017 10-K 2019-01-11
Q2 2017 41M +6.5M +18.9% Jul 31, 2017 10-Q 2017-09-11
Q1 2017 40.4M +6.12M +17.9% Apr 30, 2017 10-Q 2017-06-06
Q4 2016 40.2M +6.25M +18.4% Jan 31, 2017 10-Q 2017-03-10
Q3 2016 40M +6.47M +19.3% Oct 31, 2016 10-K 2017-12-21
Q2 2016 34.5M +3M +9.51% Jul 31, 2016 10-Q 2016-09-08
Q1 2016 34.3M +6.77M +24.6% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 33.9M +9.91M +41.3% Jan 31, 2016 10-Q 2016-02-26
Q3 2015 33.6M +13.9M +71% Oct 31, 2015 10-K 2017-01-09
Q2 2015 31.5M +12M +61.4% Jul 31, 2015 10-Q 2015-09-11
Q1 2015 27.5M +8.41M +44% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 24M +10M +71.5% Jan 31, 2015 10-Q 2015-03-13
Q3 2014 19.6M +5.91M +43.1% Oct 31, 2014 10-K 2016-01-08
Q2 2014 19.5M +14.6M +298% Jul 31, 2014 10-Q 2014-09-09
Q1 2014 19.1M -554M -96.7% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 14M -479M -97.2% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 13.7M +10.6M +334% Oct 31, 2013 10-K 2015-01-06
Q2 2013 4.9M -370M -98.7% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 573M +286M +99.8% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 493M +215M +77.1% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 3.16M -247M -98.7% Oct 31, 2012 10-K 2014-01-29
Q2 2012 375M +135M +56.3% Jul 31, 2012 10-Q/A 2012-10-04
Q1 2012 287M Apr 30, 2012 10-Q/A 2012-10-18
Q4 2011 279M Jan 31, 2012 10-Q/A 2012-10-18
Q3 2011 250M +52.1M +26.3% Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 240M Jul 31, 2011 10-Q 2011-09-12
Q3 2010 198M Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.